C4-deficient guinea pigs were characterized in 1971 as being completely genetically and functionally deficient in C4 (Ellman, L. et al. (1970); Ellman, L. et al. (1971); Frank, M.M., et al. (1971)).This line of guinea pigs has been maintained and used extensively for the characterization of complement.In fact, these animals were a key element in the rediscovery and detailed characterization of the alternative pathway of complement (Ellman, L. et al. (1971); Frank, M.M., et al. (1971)).The product is tested for the absence of C4 by functional assays for classical pathway activity. C4-D guinea pig serum reconstituted with human C4 is certified to possess a functional classical pathway for complement activation after reconstitution (Morgan, B.P. (2000); Dodds, A.W. and Sim, R.B. (1997)).The absence of C4 would also be predicted to prevent complement activation by the lectin pathway, but the function of this pathway is not tested.
(For full product description see link...)
Complement Technology,Inc。(CompTech)致力于为生物医学研究界提供最高质量的补充试剂。CompTech的业主和员工在补充领域拥有超过80年的综合经验。我们是我们销售的补充试剂的原始制造商,我们努力成为最优质试剂的最低成本供应商。我们不断扩大我们生产的试剂系列,以满足不断变化的研究需求。我们欢迎您提供所需新试剂的建议。